🇺🇸 FDA
Patent

US 11197883

Inhibition of stress granule formation through manipulation of UBAP2L

granted A61KA61K31/7105

Quick answer

US patent 11197883 (Inhibition of stress granule formation through manipulation of UBAP2L) held by The Regents of the University of California expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/7105